Navigation Links
Noninvasive Glaucoma Test Might Speed Up Detection
Date:12/1/2010

WEDNESDAY, Dec. 1 (HealthDay News) -- A test that measures the function of nerve cells in the retina may detect glaucoma at an early stage and help doctors evaluate the effectiveness of treatments, a new study has found.

Diagnosing glaucoma as early as possible -- before it destroys the optic nerve -- is key to preventing vision loss, according to the researchers, from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine.

The test, known as a pattern electroretinogram optimized for glaucoma screening, measures the electrical activity of the retina as a person looks at an alternating pattern of black and white lines.

The test can detect dysfunction and abnormal changes in retinal ganglion cells (RGCs) that appear early in the glaucoma process, the researchers said, making it potentially valuable as a non-invasive method of detection.

Studying 47 people with glaucoma who had surgery because their intraocular pressure could not be controlled by medications, the researchers said the test was able to show reversal of RGC dysfunction and reduced intraocular pressure after the operations.

However, larger studies are needed to confirm the results, study co-leader Mitra Sehi said in a news release from the American Academy of Ophthalmology.

More information

The U.S. National Eye Institute has more about glaucoma.

SOURCE: American Academy of Ophthalmology, news release, Dec. 1, 2010

-- Robert Preidt

SOURCE: American Academy of Ophthalmology, news release, Dec. 1, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. New research shows innovative respiratory stress test can quickly detect significant coronary artery disease in a noninvasive setting
2. Noninvasive combination technique may reduce number of breast biopsies
3. Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer
4. Noninvasive Test for Colon Cancer Shows Promise in Early Trial
5. Noninvasive brain stimulation helps improve motor function in stroke patients
6. Glaucoma Begins in Mid-Brain, Not in Eye, Research Shows
7. Waiting Safe for Some at Risk of Glaucoma
8. New Contact Lenses Could Improve Glaucoma Treatment
9. Glaucoma Cases on the Rise in U.S.
10. St. Michaels doctor wins $50,000 N.Y. Academy of Medicine Glaucoma Prize
11. Excess Weight May Protect Women From Type of Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Noninvasive Glaucoma Test Might Speed Up Detection
(Date:3/28/2017)... ... 28, 2017 , ... Resoundant, Inc., the developer of ... Healthineers annual customer education symposium, a world-class learning conference that offers educational content ... - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid ... Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March 1, and ... regarding thyroid function. , Dr. Izabella Wentz is a licensed pharmacist and ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... share of all holidays (IBT World Travel Trends Report). As travelers visit both ... a range in temperatures, and prolonged sun exposure. In response, the outdoor industry ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Alert Sentry ... of MPERS (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These ... market. The first of their kind, the iSAFE and iSAFE Plus offer direct GPS ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... REDWOOD CITY, Calif. , March 28, 2017 ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that the European Medicines Agency ... (sufentanil sublingual tablet, 30 mcg) Marketing Authorisation Application ... review of the MAA is underway. The MAA ...
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017 ... to reach USD 8.0 billion by 2025, according to ... increasing incidence of infectious diseases and cancer is expected ... in disease diagnosis over the coming years. In addition, ... of autologous and allogenic stem cell therapy, due to ...
Breaking Medicine Technology: